Society of Nuclear Medicine

SHERPA: Unknown

People

  1. Humm
    Humm
  2. Zanzonico
    Zanzonico
  3. Schoder
    Schoder
  4. Lewis
    Lewis
  5. O'Donoghue
    O'Donoghue
  6. Blasberg
    Blasberg
  7. Morris
    Morris
  8. Kesner
    Kesner
  9. Carter
    Carter
  10. Scheinberg
    Scheinberg

Groups

  1. Radiology, Department of (703)
  2. Molecular Imaging and Therapy Service (577)
  3. GSK Faculty (478)
  4. Sloan Kettering Institute Faculty (388)
  5. Molecular Pharmacology and Chemistry Program Faculty (383)
  6. Medical Physics (308)
  7. Sloan Kettering Institute Postdocs (271)
  8. Department of Medicine (217)
  9. Radiochemistry and Imaging Sciences Service (213)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (183)
Search Within
Formats
  1. Journal Article (469)
  2. Meeting Abstract (422)
  3. Review (32)
  4. Editorial (25)
  5. Miscellaneous (7)
  6. Correspondence (6)
  7. Guidelines (3)
  8. Conference Paper (2)
  9. Research Letter (1)
Groups
  1. Radiology, Department of (703)
  2. Molecular Imaging and Therapy Service (577)
  3. GSK Faculty (478)
  4. Sloan Kettering Institute Faculty (388)
  5. Molecular Pharmacology and Chemistry Program Faculty (383)
  6. Medical Physics (308)

More Groups

People
  1. Steven Larson (294)
  2. John Humm (116)
  3. Pat Zanzonico (99)
  4. Ronald Finn (99)
  5. Heiko Schoder (97)
  6. Jason Lewis (90)

More People

Years
  1. 2025 (33)
  2. 2024 (51)
  3. 2023 (54)
  4. 2022 (24)
  5. 2021 (38)
  6. 2020 (47)

More Years

Publications
  1. Journal of Nuclear Medicine (967)

Results (967)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reflections on the demand for PSMA- and SSTR-targeted radiopharmaceutical therapies: Why we were wrong (and why we will be right eventually)
    Editorial

    Czernin, J.; Bodei, L.; Modlin, I.; Calais, J.
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Dosimetry software for theranostic applications: Current capabilities and future prospects
    Review

    Kesner, A. L.; Brosch-Lenz, J.; Gear, J.; Lassmann, M.
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Diuresis during (18)F-flotufolastat (rhPSMA-7.3) PET/CT improves recurrence detection after prostatectomy: A prospective phase II trial
    Journal Article

    Lawal, I. O.; Mushtaq, A.; Jani, A. B.; Rupji, M.; Dhere, V. R.; Patel, S. A.; Bilen, M. A.; Patel, P. R.; Sebastian, N. T.; Switchenko, J. M.; more...
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Survival outcomes and dosimetric analysis of Iomab-B (131I-apamistamab) followed by allogeneic hematopoietic cell transplant for patients with TP53 mutated relapsed/refractory AML
    Meeting Abstract

    Natwa, M.; Leung, E.; Chen, M. K.; Wagner, R.; Yap, W.; Griffeth, L.; Wiseman, G.; Wahl, R.; Avril, N.; Lamonica, D.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • FRONTIER: FAPi Radioligand OpeN-label, phase 1 study to evaluate safety, Tolerability and dosImetry of [Lu-177]-PNT6555; a dose Escalation study for tReatment of patients with select solid tumors
    Meeting Abstract

    Juneau, D.; Kavan, P.; Metser, U.; Abikhzer, G.; Bodei, L.; Liberman, M.; Taunk, N.; O'Reilly, E. M.; Ma, J. S.; Cioci, R.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • The scientific and clinical potentials of imaging cytotoxic T-cells using Zr-89 crefmirlimab berdoxam
    Meeting Abstract

    Schmiedehausen, K.; Aarntzen, E.; Omidvari, N.; Van den Abbeele, A.; Scott, A.; Hao, C.; Zang, P.; Cherry, S.; Peeters, E.; Wilson, I.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Usability of PETSIRD, the PET Raw Data open format of the Emission Tomography Standardization Initiative (ETSI): Results from ETSI's first hackathon
    Meeting Abstract

    Karakatsanis, N.; Atkinson, D.; Buscaron, C.; Cheng, J. C. K.; Coussat, A.; Deidda, D.; Efthimiou, N.; Elmoujarkach, E.; Goncharov, F.; Han, F.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Exploratory analysis of bone marrow dosimetry from the randomized phase 3 SIERRA trial of Iomab-B (131I-apamistamab) prior to HCT in relapsed/refractory acute myeloid leukemia
    Meeting Abstract

    Pandit-Taskar, N.; Natwa, M.; Chen, M. K.; Wagner, R.; Yap, W.; Griffeth, L.; Wiseman, G.; Passalaqua, S.; Avril, N.; Lamonica, D.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Computational nuclear oncology for precision radiopharmaceutical therapies
    Meeting Abstract

    Yusufaly, T.; Roncali, E.; Uribe, C.; Shi, K. Y.; Bradshaw, T.; Jha, A.; Strigari, L.; Currie, G.; McMeekin, H.; Schwartz, J.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Radiolabelling of human mesenchymal and hematopoietic stem cells with [89Zr]Zr-Df-Bz-NCS for possible future stem cell therapy tracking with PET
    Meeting Abstract

    Kahts, M.; Mellet, J.; Durandt, C.; Moodley, K.; Summers, B.; Ebenhan, T.; Zeevaart, J. R.; Aras, O.; Pepper, M.
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save

    • Society of Nuclear Medicine – authorized name for: